Skip to main content
Premium Trial:

Request an Annual Quote

Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma

NEW YORK – Castle Biosciences said Thursday that it is working in collaboration with the National Cancer Institute to link test results from its DecisionDx-Melanoma assay with data from the Surveillance, Epidemiology, and End Results (SEER) Program’s registries on cutaneous melanoma cases.

According to the company, initial retrospective analyses of database records up to 2018 have reflected results of its prior studies. Melanoma patients tested with its assay — a gene expression test intended to assess the risk of metastasis or recurrence — had better outcomes than untested individuals.

The firm now plans to continue the collaboration, linking SEER cases diagnosed post-2018 with DecisionDx-Melanoma test results.

The new data, shared in a poster presentation at the 2022 Winter Clinical Dermatology Conference in January, described results from an analysis of SEER data for a subset of cutaneous melanoma cases recorded between 2013 and 2018.

Researchers identified individuals in the database who had DecisionDx testing and matched them with an untested cohort with similar clinical, pathological, and demographic features.

Investigators reported that patients tested with DecisionDx-Melanoma had better overall survival rates than patients who had not been tested. Those who received a DecisionDx-Melanoma high-risk result had a tenfold increase in death rate compared to patients who received a low-risk result.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.